• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过对预后评分进行线性调整来提高随机试验估计的效率。

Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score.

机构信息

UC Berkeley Center for Targeted Learning, Berkeley, CA, USA.

Unlearn.AI, Inc., San Francisco, CA, USA.

出版信息

Int J Biostat. 2021 Dec 22;18(2):329-356. doi: 10.1515/ijb-2021-0072. eCollection 2022 Nov 1.

DOI:10.1515/ijb-2021-0072
PMID:34957728
Abstract

Estimating causal effects from randomized experiments is central to clinical research. Reducing the statistical uncertainty in these analyses is an important objective for statisticians. Registries, prior trials, and health records constitute a growing compendium of historical data on patients under standard-of-care that may be exploitable to this end. However, most methods for historical borrowing achieve reductions in variance by sacrificing strict type-I error rate control. Here, we propose a use of historical data that exploits linear covariate adjustment to improve the efficiency of trial analyses without incurring bias. Specifically, we train a prognostic model on the historical data, then estimate the treatment effect using a linear regression while adjusting for the trial subjects' predicted outcomes (their ). We prove that, under certain conditions, this prognostic covariate adjustment procedure attains the minimum variance possible among a large class of estimators. When those conditions are not met, prognostic covariate adjustment is still more efficient than raw covariate adjustment and the gain in efficiency is proportional to a measure of the predictive accuracy of the prognostic model above and beyond the linear relationship with the raw covariates. We demonstrate the approach using simulations and a reanalysis of an Alzheimer's disease clinical trial and observe meaningful reductions in mean-squared error and the estimated variance. Lastly, we provide a simplified formula for asymptotic variance that enables power calculations that account for these gains. Sample size reductions between 10% and 30% are attainable when using prognostic models that explain a clinically realistic percentage of the outcome variance.

摘要

从随机临床试验中估计因果效应是临床研究的核心。减少这些分析中的统计不确定性是统计学家的一个重要目标。登记处、先前的试验和健康记录构成了越来越多的标准治疗下患者的历史数据汇编,这些数据可能可以用于达到这一目的。然而,大多数用于历史借鉴的方法通过牺牲严格的Ⅰ型错误率控制来实现方差的减少。在这里,我们提出了一种利用历史数据的方法,通过线性协变量调整来提高试验分析的效率,而不会产生偏差。具体来说,我们在历史数据上训练一个预测模型,然后使用线性回归估计治疗效果,同时调整试验对象的预测结果(他们的 )。我们证明,在某些条件下,这种预后协变量调整程序在一大类估计器中达到了最小方差。当这些条件不满足时,预后协变量调整仍然比原始协变量调整更有效,并且效率的提高与预测模型的预测准确性成正比,超出了与原始协变量的线性关系。我们使用模拟和对阿尔茨海默病临床试验的重新分析来证明这种方法,并观察到均方误差和估计方差的显著减少。最后,我们提供了一个简化的渐近方差公式,使能够进行考虑这些收益的功效计算。当使用可以解释结果方差的临床合理百分比的预测模型时,可以实现 10%至 30%的样本量减少。

相似文献

1
Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score.通过对预后评分进行线性调整来提高随机试验估计的效率。
Int J Biostat. 2021 Dec 22;18(2):329-356. doi: 10.1515/ijb-2021-0072. eCollection 2022 Nov 1.
2
Prognostic score-based model averaging approach for propensity score estimation.基于预后评分的模型平均倾向评分估计方法。
BMC Med Res Methodol. 2024 Oct 3;24(1):228. doi: 10.1186/s12874-024-02350-y.
3
"Super-covariates": Using predicted control group outcome as a covariate in randomized clinical trials.“超级协变量”:在随机临床试验中,将预测的对照组结局用作协变量。
Pharm Stat. 2023 Nov-Dec;22(6):1062-1075. doi: 10.1002/pst.2329. Epub 2023 Aug 8.
4
More efficient and inclusive time-to-event trials with covariate adjustment: a simulation study.具有协变量调整的更高效和更具包容性的生存时间试验:一项模拟研究。
Trials. 2023 Jun 6;24(1):380. doi: 10.1186/s13063-023-07375-0.
5
Dynamic use of historical controls in clinical trials for rare disease research: A re-evaluation of the MILES trial.在罕见病研究的临床试验中动态使用历史对照:对 MILES 试验的重新评估。
Clin Trials. 2023 Jun;20(3):223-234. doi: 10.1177/17407745231158906. Epub 2023 Mar 17.
6
Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?受限平均生存时间:协变量调整能否提高随机临床试验的精度?
Clin Trials. 2018 Apr;15(2):178-188. doi: 10.1177/1740774518759281. Epub 2018 Mar 4.
7
On the relevance of prognostic information for clinical trials: A theoretical quantification.预后信息对临床试验的相关性:理论定量。
Biom J. 2023 Jan;65(1):e2100349. doi: 10.1002/bimj.202100349. Epub 2022 Aug 7.
8
Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?随机对照试验中的基线特征与统计效能:选择、预后靶向还是协变量调整?
Crit Care Med. 2009 Oct;37(10):2683-90. doi: 10.1097/ccm.0b013e3181ab85ec.
9
An evaluation of inverse probability weighting using the propensity score for baseline covariate adjustment in smaller population randomised controlled trials with a continuous outcome.评价在较小人群随机对照试验中使用倾向评分进行基线协变量调整的逆概率加权法,该试验的结局变量为连续型变量。
BMC Med Res Methodol. 2020 Mar 23;20(1):70. doi: 10.1186/s12874-020-00947-7.
10
Designing efficient randomized trials: power and sample size calculation when using semiparametric efficient estimators.设计高效的随机临床试验:使用半参数有效估计量时的功效和样本量计算。
Int J Biostat. 2021 Aug 6;18(1):151-171. doi: 10.1515/ijb-2021-0039.

引用本文的文献

1
Prediction-powered inference for clinical trials: application to linear covariate adjustment.临床试验的预测驱动推理:在线性协变量调整中的应用。
BMC Med Res Methodol. 2025 Aug 29;25(1):204. doi: 10.1186/s12874-025-02647-6.
2
Treatment Comparison for a Single Arm Study Utilizing External Control: Performing Inference when Imputing Potential Outcomes.利用外部对照的单臂研究的治疗比较:在推算潜在结果时进行推断
Ther Innov Regul Sci. 2025 Jul 22. doi: 10.1007/s43441-025-00839-2.
3
Prognostic adjustment with efficient estimators to unbiasedly leverage historical data in randomized trials.
使用有效估计量进行预后调整,以在随机试验中无偏地利用历史数据。
Int J Biostat. 2025 Mar 11;21(1):1-15. doi: 10.1515/ijb-2024-0018. eCollection 2025 May 1.
4
Predicted natural progression as an Alzheimer's prognostic covariate improves the precision of lecanemab efficacy assessments and clinical trial efficiency.作为阿尔茨海默病预后协变量的预测自然病程可提高lecanemab疗效评估的准确性和临床试验效率。
Alzheimers Dement. 2025 Mar;21(3):e70045. doi: 10.1002/alz.70045.
5
Prediction-powered Inference for Clinical Trials.临床试验的预测驱动推理
medRxiv. 2025 Jan 18:2025.01.15.25320578. doi: 10.1101/2025.01.15.25320578.
6
Development of a conceptual framework for defining trial efficiency.定义试验效率的概念框架的发展。
PLoS One. 2024 May 23;19(5):e0304187. doi: 10.1371/journal.pone.0304187. eCollection 2024.
7
Predicting clinical progression trajectories of early Alzheimer's disease patients.预测早期阿尔茨海默病患者的临床进展轨迹。
Alzheimers Dement. 2024 Mar;20(3):1725-1738. doi: 10.1002/alz.13565. Epub 2023 Dec 13.
8
The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives.人工智能/机器学习在药物发现、开发、临床测试和制造中的崭露头角:FDA 的观点。
Drug Des Devel Ther. 2023 Sep 6;17:2691-2725. doi: 10.2147/DDDT.S424991. eCollection 2023.
9
On the relevance of prognostic information for clinical trials: A theoretical quantification.预后信息对临床试验的相关性:理论定量。
Biom J. 2023 Jan;65(1):e2100349. doi: 10.1002/bimj.202100349. Epub 2022 Aug 7.